Oppenheimer Upgrades Endologix (ELGX) to Outperform

Go back to Oppenheimer Upgrades Endologix (ELGX) to Outperform

JPMorgan Upgrades Endologix (ELGX) to Overweight

August 6, 2015 6:46 AM EDT

JPMorgan upgraded Endologix (NASDAQ: ELGX) from Neutral to Overweight with a price target of $17.00.

For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.

Shares of Endologix closed at $12.05 yesterday.

... More